A Delaware bill mandating health insurance coverage for HIV prevention drugs PrEP and PEP has passed both the House and ...

We read with interest Huang et al.’s (2026) retrospective cohort study of dropless cataract surgery, which compared 291 eyes receiving intraoperative sub-Tenon’s triamcinolone acetonide with 3016 eyes ...

FDA approves ensitrelvir for COVID-19 postexposure prophylaxis following phase 3 data showing efficacy against Omicron symptoms. The FDA recently approved ensitrelvir (Xocova; Shionogi), an ...

Subscribe to improve your user experience ...

The rise of antimicrobial resistance (AMR) represents a major threat to human health, with predictions suggesting that AMR-related deaths will surpass those from cancer by 2050 if left unaddressed.

Among 1818 females whose PS activity was ≤ 55%, 35 were diagnosed with PS deficiency including 20 who used prophylactic anticoagulation with LMWH during pregnancy and 15 who did not receive LMWH or ...

Antibiotic prophylaxis with a single dose of ciprofloxacin reduces bacteriuria and urinary tract infections (UTIs) after shockwave lithotripsy for urolithiasis. A single dose of ciprofloxacin before ...

Arlington, VA –The Centers for Disease Control and Prevention (CDC), on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to ...

Prevention doesn’t come easy. The bar is high. The decision to act medically because an untoward outcome could occur means creating intervention side-effect risk that’s otherwise absent. Large patient ...

New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated with no safety ...

Creatively punning dialogue and action-packed comics-style panels winningly combine in this highly entertaining princess smackdown. Courtesy of “the WPW: World Princess Wrestling,” a global cast of ...

Allogeneic peripheral-blood stem-cell transplantation (SCT) from a matched related donor after myeloablative conditioning is the preferred curative treatment for patients with high-risk blood cancers.